Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: Canada Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20016
20041
20051
20063
20072
20081
20091
20101
20112
20121
20132
20143
20161
20172
20191
20201
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated5
Recruiting3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
Celgene2
Incyte Corporation2
NCIC Clinical Trials Group2
AHS Cancer Control Alberta1
Alliance for Clinical Trials in Oncology1
Amgen1
Arcus Biosciences, Inc.1
AstraZeneca1
Centre hospitalier de l'Université de Montréal (CHUM)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms34
Neoplasms4
Endocrine Gland Neoplasms3
Pancreatic Diseases3
Adenocarcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine System Diseases2
Neoplasm Metastasis2
Neoplasms by Site2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.